Relationship between the Serum Concentration of 7α-Hydroxycholesterol and Fecal Bile Acid Excretion in Humans

References

• Dietschy J M. Regulation of cholesterol metabolism in man and other species. Klin Wochenschr 1984; 62: 338–45
   PubMedGoogle Scholar
• Björkhem I. Mechanism of bile acid biosynthesis in mammalian liver. Sterols and bile acids, H Danielsson, J Sjövall. Elsevier, Amsterdam 1985; 231–78
   Google Scholar
• Lindstedt S. The turnover of cholic acid in man. Acta Physiol Scand 1957; 40: 1–9
   PubMedGoogle Scholar
• Grundy S M, Ahrens E J, Jr, Miettinen T A. Quantitative isolation and gas‐liquid chromatographic analysis of total fecal bile acids. J Lipid Res 1965; 6: 397–410
   PubMed Web of Science ®Google Scholar
• Stellaard F, Sackmann M, Berr F, Paumgartner G. Simultaneous determination of pool sizes and fractional turnover rates of deoxycholic acid, cholic acid, and chenodeoxycholic acid in man by isotope dilution with 2H and 13C labels and serum sampling. Biomed Environ Mass Spectrom 1987; 14: 609–11
   PubMedGoogle Scholar
• Björkhem I, Reihnér E, Angelin B, Ewerth S, Akerlund J ‐E, Einarsson K. On the possible use of the serum level of 7α‐hydroxycholesterol as a marker for increased activity of the cholesterol 7α‐hydroxylase in humans. J Lipid Res 1987; 28: 889–94
   PubMed Web of Science ®Google Scholar
• Oda H, Yamashita H, Kosahara K, Kuroki S, Nakayama F. Esterified and total 7α‐hydroxycholesterol in human serum as an indicator for hepatic bile acid synthesis. J Lipid Res 1990; 31: 2209–18
   PubMed Web of Science ®Google Scholar
• Yoshida T, Honda A, Tanaka N, Matsuzaki Y, He B, Osuga T, et al. Simultaneous determination of mevalonate and 7α‐hydroxy‐cholesterol in human plasma by gas chromatography‐mass spectrometry as indices of cholesterol and bile acid biosynthesis. J Chromatogr 1993; 613: 185–93
   PubMedGoogle Scholar
• Axelson M, Björkhem I, Reihnér E, Einarsson K. The plasma level of 7α‐hydroxy‐4‐cholesten‐3‐one reflects the activity of hepatic cholesterol 7α‐hydroxylase in man. FEBS Lett 1991; 284: 216–8
   PubMed Web of Science ®Google Scholar
• Hahn C, Reichel C, von Bergmann K. Serum concentration of 7α‐hydroxycholesterol as an indicator of bile acid synthesis in humans. J Lipid Res 1995; 36: 2059–66
   PubMedGoogle Scholar
• Czubayko F, Beumers B, Lammsfuss S, Lütjohann D, von Bergmann K. A simplified micro‐method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res 1991; 32: 1861–8
   PubMedGoogle Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Björkhem I, Miettinen T A, Reihnér E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG‐CoA reductase in human liver. J Lipid Res 1987; 28: 1137–43
   PubMed Web of Science ®Google Scholar
• Kempen H JM, Glatz J FC, Gevers Leuven J A, van der Voort H A, Katan M B. Serum lathosterol concentration is an indicator of whole‐body cholesterol synthesis in humans. J Lipid Res 1988; 29: 1149–55
   PubMed Web of Science ®Google Scholar
• Parker T S, McNamara D J, Brown C D, Kolb R, Ahrens E H, Alberts A W, et al. Plasma mevalonate as a measure of cholesterol synthesis in man. J Clin Invest 1984; 74: 795–804
   PubMed Web of Science ®Google Scholar
• Axelson M, Sjövall J. Potential bile acid precursors in plasma‐possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. J Steroid Biochem 1990; 36: 631–40
   PubMedGoogle Scholar
• Björkhem I, Fausa O, Hopen G, Oftebro H, Pedersen J I, Skrede S. Role of the 26‐hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis. J Clin Invest 1983; 71: 142–8
   PubMed Web of Science ®Google Scholar
• Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, et al. Influence of pravastatin, a specific inhibitor of HMG‐CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med 1990; 323: 224–8
   PubMed Web of Science ®Google Scholar
• Bertolotti M, Abate N, Loria P, Dilengite M, Carubbi F, Pinetti A, et al. Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7α‐hydroxylation rates in vivo. Hepatology 1991; 14: 830–7
   PubMed Web of Science ®Google Scholar
• Mitchell J C, Logan G M, Stone B G, Duane W C. Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans. J Lipid Res 1991; 32: 71–8
   PubMed Web of Science ®Google Scholar
• Mitchell J C, Stone B G, Logan G M, Duane W C. Role of cholesterol synthesis in regulation of bile acid synthesis and biliary cholesterol secretion in humans. J Lipid Res 1991; 32: 1143–9
   PubMed Web of Science ®Google Scholar
• Hanson D S, Duane W C. Effects of lovastatin and chenodiol on bile acid synthesis, bile lipid composition, and biliary lipid secretion in healthy human subjects. J Lipid Res 1994; 35: 1462–8
   PubMed Web of Science ®Google Scholar
• Grundy S M, Bilheimer D W. Inhibition of 3‐hydroxy‐3‐methyl‐glutaryl‐CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance. Proc Natl Acad Sci USA 1984; 81: 2538–42
   PubMed Web of Science ®Google Scholar
• von Bergmann K, Leiss O. Effect of short‐term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia. Eur J Clin Invest 1984; 14: 150–154
   PubMed Web of Science ®Google Scholar
• Leiss O, Meyer‐Krahmer K, von Bergmann K. Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate. J Lipid Res 1986; 27: 713–23
   PubMed Web of Science ®Google Scholar
• Ståhlberg D, Reihnér E, Rudling M, Berglund L, Einarsson K, Angelin B. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7α‐hydroxylase. Hepatology 1995; 21: 1025–30
   PubMedGoogle Scholar
• Bertolotti M, Concari M, Loria P, Abate N, Pinetti A, Guicciardi M E, et al. Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7α‐hydroxylation in humans. Arterioscler Thromb Vasc Biol 1995; 15: 1064–9
   PubMedGoogle Scholar
• Angelin B, Hershon K C, Brunzell J D. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Natl Acad Sci USA 1987; 84: 5434–8
   PubMedGoogle Scholar
• Angelin B, Holmquist L, Leijd B, Einarsson K. Bile acid metabolism in familial dysbetalipoproteinaemia: studies in subjects with the apolipoprotein E2/2 phenotype. Eur J Clin Invest 1990; 20: 143–9
   PubMedGoogle Scholar